ScinoPharm will invest $37.6m in the construction of a high potency cytotoxic injectable plant at Tainan Science Park. ScinoPharm said the new facility will include space for R&D, quality control, washing, sterilisation, manufacturing, filling, lyophilisation, packaging, and storage. The company expects the plant to be completed in 2014.
ScinoPharm
Monday 9 July 2012
ScinoPharm invests in cytotoxic manufacturing
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment